RESEARCHER PROFILE

Lanying Du

← Back to Georgia State University

L

Georgia State University

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approachesInfluenza Virus Research StudiesMonoclonal and Polyclonal Antibodies Research

Lanying Du works in SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, vaccines and immunoinformatics approaches, Influenza Virus Research Studies, Monoclonal and Polyclonal Antibodies Research. Recorded institutional associations include Georgia State University.

196Publications
19,510Citations
70H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    2009 · 1,661 citations
  2. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

    2020 · 1,650 citations
  3. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

    2020 · 1,343 citations
  4. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

    2020 · 847 citations
  5. Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

    2019 · 662 citations
  6. Recent advances in the detection of respiratory virus infection in humans

    2020 · 550 citations
  7. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

    2019 · 501 citations
  8. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses

    2020 · 425 citations
  9. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

    2014 · 388 citations
  10. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

    2020 · 366 citations
  11. An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

    2020 · 330 citations
  12. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release

    2006 · 321 citations
  13. MERS-CoV spike protein: a key target for antivirals

    2016 · 299 citations
  14. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

    2014 · 281 citations
  15. Receptor Usage and Cell Entry of Porcine Epidemic Diarrhea Coronavirus

    2015 · 259 citations
  16. Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies

    2014 · 233 citations
  17. Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

    2020 · 199 citations
  18. Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4 -transgenic mice infected with MERS-CoV

    2018 · 195 citations
  19. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model

    2006 · 182 citations
  20. Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development

    2013 · 178 citations
  21. Learning from the past: development of safe and effective COVID-19 vaccines

    2020 · 170 citations
  22. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations

    2015 · 158 citations
  23. Current advancements and potential strategies in the development of MERS-CoV vaccines

    2014 · 158 citations
  24. A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines

    2013 · 157 citations
  25. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

    2020 · 149 citations

← Return to the university profile